AbstractObjectives. The effects of both temporary and permanent dual-chamber pacing (DCP) were evaluated in symptomatic pediatric patients with hypertrophic obstructive cardiomyopathy (HOCM) unresponsive to medications.Background. Permanent DCP pacing can reduce left ventricular outflow tract (LVOT) gradient and relieve symptoms in adult patients with HOCM.Methods. Ten patients (mean [±SD] age 11.1 ± 6 years, range 1 to 17.5) with HOCM and a Doppler LVOT gradient ≥40 mm Hg were studied. The seven patients showing hemodynamic improvement during temporary pacing at cardiac catheterization underwent surgical implantation of a permanent DCP system. The effects of permanent pacing were evaluated using a questionnaire, Doppler evaluation, treadmi...
We treated a patient with hypertrophic obstructive cardiomyopathy (HOCM) who underwent DDD pacing th...
INTRODUCTION Hypertrophic cardiomyopathy (HCM) patients with left ventricular (LV) mid-cavity obs...
INTRODUCTION: Hypertrophic cardiomyopathy (HCM) patients with left ventricular (LV) mid-cavity obstr...
AbstractObjectives. The effects of both temporary and permanent dual-chamber pacing (DCP) were evalu...
SummaryBackgroundThe very long-term effects of dual chamber pacing as a primary treatment for hypert...
Several studies indicate that short term, dual chamber (DOD) pacing relieves symptoms and reduces LV...
AbstractObjectives. In a double-blind, randomized, crossover trial we sought to evaluate the effect ...
A 60-year-old man with hypertrophic obstructive cardiomyopathy (HOCM) was implanted dual-chamber ICD...
Background Uncontrolled studies have shown that short atrioventricular delay dual chamber pacing red...
Background We previously reported that 6 to 12 weeks of dual-chamber (DDD) pacing results in clinica...
AbstractObjectives. This study sought to evaluate prospectively the acute hemodynamic effect of dual...
International audienceBackground The very long-term effects of dual chamber pacing as a primary trea...
Although attempts have been made to treat hypertrophic obstructive cardiomyopathy with right ventric...
Obstruction in hypertrophic cardiomyopathy (HCM) benefits from atrioventricular (AV) pacing with api...
BACKGROUND: Uncontrolled studies have shown that short atrioventricular delay dual chamber pacing re...
We treated a patient with hypertrophic obstructive cardiomyopathy (HOCM) who underwent DDD pacing th...
INTRODUCTION Hypertrophic cardiomyopathy (HCM) patients with left ventricular (LV) mid-cavity obs...
INTRODUCTION: Hypertrophic cardiomyopathy (HCM) patients with left ventricular (LV) mid-cavity obstr...
AbstractObjectives. The effects of both temporary and permanent dual-chamber pacing (DCP) were evalu...
SummaryBackgroundThe very long-term effects of dual chamber pacing as a primary treatment for hypert...
Several studies indicate that short term, dual chamber (DOD) pacing relieves symptoms and reduces LV...
AbstractObjectives. In a double-blind, randomized, crossover trial we sought to evaluate the effect ...
A 60-year-old man with hypertrophic obstructive cardiomyopathy (HOCM) was implanted dual-chamber ICD...
Background Uncontrolled studies have shown that short atrioventricular delay dual chamber pacing red...
Background We previously reported that 6 to 12 weeks of dual-chamber (DDD) pacing results in clinica...
AbstractObjectives. This study sought to evaluate prospectively the acute hemodynamic effect of dual...
International audienceBackground The very long-term effects of dual chamber pacing as a primary trea...
Although attempts have been made to treat hypertrophic obstructive cardiomyopathy with right ventric...
Obstruction in hypertrophic cardiomyopathy (HCM) benefits from atrioventricular (AV) pacing with api...
BACKGROUND: Uncontrolled studies have shown that short atrioventricular delay dual chamber pacing re...
We treated a patient with hypertrophic obstructive cardiomyopathy (HOCM) who underwent DDD pacing th...
INTRODUCTION Hypertrophic cardiomyopathy (HCM) patients with left ventricular (LV) mid-cavity obs...
INTRODUCTION: Hypertrophic cardiomyopathy (HCM) patients with left ventricular (LV) mid-cavity obstr...